Company Filing History:
1 out of 291 
1 out of 76 
Years Active: 2017
Title: Andrea Ditadi: A Pioneer in Hematopoietic Progenitor Enrichment
Introduction
Andrea Ditadi is a distinguished inventor based in Toronto, Canada, known for her significant contributions to stem cell research. With one patent to her name, she has made a noteworthy impact in the field of hematopoietic progenitor enrichment, an area critical for advancements in regenerative medicine.
Latest Patents
Ditadi's patent, titled "Populations of hematopoietic progenitors and methods of enriching stem cells therefor," outlines a pioneering method for enhancing populations of stem cells to isolate hematopoietic progenitors. This method involves inducing hematopoietic differentiation in human embryonic or induced pluripotent stem cells, followed by sorting based on the expression of specific markers such as CD43, CD34, CD31, and CD144. The unique fractions obtained, specifically those characterized as CD34+CD43−, CD31+CD43−, and CD144+CD43−, provide new avenues for stem cell research and potential therapies.
Career Highlights
Throughout her career, Andrea Ditadi has been affiliated with esteemed institutions, including University Health Network and Sunnybrook Research Institute. These organizations have provided her with a platform to innovate and collaborate in the field of stem cell research, contributing significantly to scientific knowledge and application.
Collaborations
Ditadi has had the opportunity to collaborate with notable researchers such as Gordon Keller and Juan Carlos Zuniga-Pflucker. These collaborations have enriched her work, fostering an environment of innovation and discovery that enhances the understanding and capabilities within hematopoietic research.
Conclusion
Andrea Ditadi stands out as a prominent figure in the field of stem cell research, with her innovative patent highlighting the potential for enriched stem cell populations in therapeutic applications. Her collaborations and work in renowned institutions underscore her commitment to advancing science, making a lasting impact on the landscape of regenerative medicine.